New ointment in the treatment for Skin Warts

Safety and efficacy of a formulation of a novel triple combination paint in the management of cutaneous warts - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073543

Enrollment

Registered

2024-09-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B079- Viral wart, unspecified

Interventions

Intervention1: Topical formulation of triple combination of salicylic acid, hydrogen peroxide and thuja occidentalis: The intervention involves the development and application of a novel topical formu

Eligibility

Inclusion criteria

Inclusion criteria: Participants aged 18 years to 60 years with clinically diagnosed cutaneous warts.

Exclusion criteria

Exclusion criteria: The following participants are exluded from the study: Pregnant or lactating women Individuals with immunodeficiency disorders individuals having allergy to any component of the triple combination paint

Design outcomes

Primary

Measure	Time frame
To assess the improvement in cutaneous wartsTimepoint: On day 10, day 24, every two weeks thereafter	—

Secondary

Measure	Time frame
To assess the complicationsTimepoint: On day 10, day 24, every two weeks thereafter	—

Countries

India

Contacts

Public ContactDr Boney Priya P Jose

Saveetha Medical College and Hospital

drnarasimhalu@yahoo.co.in9445188988

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026